Home Newsfeeds HC Wainwright & Co. Maintains Buy on HIVE Blockchain Techs, Maintains $5 Price Target

HC Wainwright & Co. Maintains Buy on HIVE Blockchain Techs, Maintains $5 Price Target

HC Wainwright & Co. analyst Mike Colonnese maintains HIVE Blockchain Techs (NASDAQ:HIVE) with a Buy and maintains $5 price target.

byBenzinga Newsdesk

February 22, 2023

1 minute read

HC Wainwright & Co. analyst Mike Colonnese maintains HIVE Blockchain Techs (NASDAQ:HIVE) with a Buy and maintains $5 price target.

These Analysts Revise Price Targets On CrowdStrike Following Q1 Results

By Lisa Levin

June 1, 7:18 AM

CrowdStrike Holdings Inc (NASDAQ: CRWD) posted better-than-expected earnings for its first quarter.

CRWD

OMV-ADNOC In Talks To Create Over $30B Chemicals & Plastics Firm: Report

By Lekha Gupta

July 5, 5:52 AM

Austria's OMV AG (OTCPK: OMVKY) (OTCPK: OMVJF) is in talks with Abu Dhabi National Oil Co. (ADNOC) to combine the companies, Borouge Plc and Borealis AG, to form a chemicals and plastics company worth over $30 billion.

OMVJF

Salarius Pharmaceuticals Announces Plans To Explore Strategic Alternatives And Implement Measures To Extend Its Resources

By Happy Mohamed

August 8, 5:59 PM

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new treatment

SLRX

Dow Tumbles 150 Points; US House Prices Rise in July

By Lisa Levin

September 26, 9:46 AM

U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.45% to 33,852.58 while the NASDAQ fell 0.74% to 13,173.33. The S&P 500 also fell, dropping, 0.65% to 4,309.40.

CDT

HC Wainwright & Co. Maintains Buy on HIVE Blockchain Techs, Maintains $5 Price Target

Related Posts

These Analysts Revise Price Targets On CrowdStrike Following Q1 Results

OMV-ADNOC In Talks To Create Over $30B Chemicals & Plastics Firm: Report

Salarius Pharmaceuticals Announces Plans To Explore Strategic Alternatives And Implement Measures To Extend Its Resources

Dow Tumbles 150 Points; US House Prices Rise in July